← Back to Search

Procedure

Hydrafacial Treatments for Dry Skin

Phase 4
Waitlist Available
Led By Edward Lain, MD, MBA
Research Sponsored by Austin Institute for Clinical Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Healthy males and females of Fitzpatrick skin types I-VI 30-55 years of age
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to day 85
Awards & highlights

Study Summary

This trial tests Hydrafacial treatments to improve skin quality, hydration, and barrier in 30-55 year olds of all skin types. Results and patient satisfaction will be tracked.

Who is the study for?
This trial is for healthy adults aged 30-55 with any skin type (Fitzpatrick Skin Types I-VI) who agree not to start new skincare products during the study. Participants must consent to study requirements and photography. Excluded are those with sunburn, significant tans, tattoos, scars in the treatment area, history of certain cancers or untreated lesions, severe skin conditions like uncontrolled acne or psoriasis, pregnant or nursing women, and individuals with major health issues.Check my eligibility
What is being tested?
The trial tests the effects of three Hydrafacial treatments on facial skin quality using HydraFacial Elite MD System and Syndeo System along with ReGen-GF product. It's an open-label phase IV study where participants' satisfaction and changes in their skin hydration and barrier will be evaluated before and after treatment across six different cohorts based on their Fitzpatrick Skin Type.See study design
What are the potential side effects?
While specific side effects are not listed for this cosmetic procedure trial, typical reactions might include temporary redness, irritation at the site of treatment, slight swelling or tenderness post-treatment. These should resolve shortly after each session.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 30 and 55 years old with any skin type.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to day 85
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to day 85 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in facial aesthetic appearance
Change in facial skin hydration
Change in skin facial skin elasticity, wrinkles, roughness, fine lines, pigmentation, erythema, and pore size
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Hydrafacial Elite MD TreatmentExperimental Treatment2 Interventions
hree HydraFacial Elite MD Treatment will be performed 28 days apart at the Houston site.
Group II: HydraFacial Syndeo TreatmentExperimental Treatment2 Interventions
Three HydraFacial Syndeo Treatment will be performed 28 days apart at the Pflugerville site.

Find a Location

Who is running the clinical trial?

The HydraFacial CompanyUNKNOWN
Austin Institute for Clinical ResearchLead Sponsor
5 Previous Clinical Trials
125 Total Patients Enrolled
Edward Lain, MD, MBAPrincipal InvestigatorAustin Institute for Clinical Research
6 Previous Clinical Trials
156 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still room for volunteers in this investigation?

"Based on the information hosted by clinicaltrials.gov, this medical trial is no longer actively recruiting participants. The study was initially posted on December 1st 2023 and subsequently updated October 13th 2023. However, a plethora of other trials are enrolling patients as we speak."

Answered by AI

Is this research offering enrollment to individuals aged 40 or older?

"This trial has a lower bound age requirement of 30 years old and an upper limit of 55."

Answered by AI

To what extent is Hydrafacial Elite MD Treatment potentially hazardous for individuals?

"Hydrafacial Elite MD Treatment has been granted Phase 4 approval, thus the safety rating is a 3."

Answered by AI

What are the eligibility criteria for participants in this trial?

"This medical experiment is seeking 30 individuals aged 30-55 who suffer from dry skin. In addition to this, potential participants must be of Fitzpatrick Skin types I-VI and free of any illnesses that could hinder their ability to take part in the trial. Furthermore, they agree not to use new skincare products for the duration of the study and are willing follow all requirements set forth by our team; signing an informed consent as well as a photography consent form."

Answered by AI

Who else is applying?

What site did they apply to?
Austin Institute for Clinical Research, Inc.
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

I am always interacted in helping with new medical and cosmetic studies.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.
2023. "Trial Assessing the Impact on Facial Skin Quality, Hydration, and Skin Barrier of Three (3) Hydrafacial Treatments in Adults of All Skin Types.". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05932732.
All > Ichthyosis
~20 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top